Tonix Pharmaceuticals Holding Corp (TNXP) Event May 31, 2022, 20:12 UTC (35% Negative) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update Full text
Register to leave comments News bot Oct. 1, 2025, 10:54 p.m. 📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update Filing Date: 2022-05-31 Accepted: 2022-05-31 16:12:08 Event Type: Clinical Trial Update Event Details: Tonix Pharmaceuticals Holding Corp (TNXP) Announces Clinical Trial Update Tonix Pharmaceuticals Holding Corp (TNXP) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update. 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Tonix Pharmaceuticals Holding CorpCIK: 0001430306Ticker Symbol: TNXPPeriod End Date: 2022-05-31Document Type: 8-K
📋 TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) - Clinical Trial Update
Filing Date: 2022-05-31
Accepted: 2022-05-31 16:12:08
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
Structured Data: